BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Liu XI, Momper JD, Rakhmanina NY, Green DJ, Burckart GJ, Cressey TR, Mirochnick M, Best BM, van den Anker JN, Dallmann A. Physiologically Based Pharmacokinetic Modeling Framework to Predict Neonatal Pharmacokinetics of Transplacentally Acquired Emtricitabine, Dolutegravir, and Raltegravir. Clin Pharmacokinet 2021;60:795-809. [PMID: 33527213 DOI: 10.1007/s40262-020-00977-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 van Hoogdalem MW, Wexelblatt SL, Akinbi HT, Vinks AA, Mizuno T. A review of pregnancy-induced changes in opioid pharmacokinetics, placental transfer, and fetal exposure: Towards fetomaternal physiologically-based pharmacokinetic modeling to improve the treatment of neonatal opioid withdrawal syndrome. Pharmacol Ther 2021;:108045. [PMID: 34813863 DOI: 10.1016/j.pharmthera.2021.108045] [Reference Citation Analysis]
2 Chaphekar N, Dodeja P, Shaik IH, Caritis S, Venkataramanan R. Maternal-Fetal Pharmacology of Drugs: A Review of Current Status of the Application of Physiologically Based Pharmacokinetic Models. Front Pediatr 2021;9:733823. [PMID: 34805038 DOI: 10.3389/fped.2021.733823] [Reference Citation Analysis]
3 Green DJ, Park K, Bhatt-Mehta V, Snyder D, Burckart GJ. Regulatory Considerations for the Mother, Fetus and Neonate in Fetal Pharmacology Modeling. Front Pediatr 2021;9:698611. [PMID: 34381745 DOI: 10.3389/fped.2021.698611] [Cited by in F6Publishing: 1] [Reference Citation Analysis]